A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

July 1, 2028

Conditions

Metastatic Solid Tumors

Interventions

DRUG

SKB107 for injection

177Lu-DOTA-IBA is a Radionuclide conjugated drugs (RDC) targeting bone.

Trial Locations (1)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

INDUSTRY